enVVeno Medical
NVNO
6 hedge funds and large institutions have $129K invested in enVVeno Medical in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less funds holding
Funds holding: 9 → 6 (-3)
51% less capital invested
Capital invested by funds: $261K → $129K (-$132K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
+$5.7K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$4.15K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$52K |
| 2 |
Jane Street
New York
|
-$13K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$4K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| 5 |
MA
MYDA Advisors
Woodmere,
New York
|
-$518 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $62K | -$13K | -25 | -16% |
|
|
MA
2
MYDA Advisors
Woodmere,
New York
| $33K | -$518 | -1 | -1% |
|
|
GIA
3
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
| $17K | +$5.7K | +11 | +48% |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $8K | – | – | – |
|
|
5
Bank of America
Charlotte,
North Carolina
| $5K | +$4.15K | +8 | +400% |
|
|
6
UBS Group
Zurich,
Switzerland
| $4K | +$1.55K | +3 | +50% |
|
|
7
Vanguard Group
Malvern,
Pennsylvania
| – | -$52K | -69 | Closed |
|
|
FIA
8
FNY Investment Advisers
New York
| – | -$4K | -6 | Closed |
|
|
9
Victory Capital Management
San Antonio,
Texas
| – | -$2K | -3 | Closed |
|
NVNO Hedge Fund Activity: Q4 2019 in Review
6 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2019, worth a combined $129K — down 51% from $261K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NVNO and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Gladstone Institutional Advisory, adding an estimated $5.7K. The largest seller was Vanguard Group, exiting entirely with an estimated $52K sold.
- 6 institutional investors held enVVeno Medical (NVNO) as of Q4 2019, down from 9 in Q3 2019.
- Funds reported $129K of enVVeno Medical stock for Q4 2019, down 51% quarter-over-quarter.
- 0 funds opened new enVVeno Medical positions in Q4 2019 and 3 closed out, a net change of -3 holders.
- The largest enVVeno Medical buyer in Q4 2019 was Gladstone Institutional Advisory, an estimated $5.7K added.
- The largest enVVeno Medical seller in Q4 2019 was Vanguard Group, an estimated $52K sold.
Based on aggregated 13F filings for Q4 2019.